Sign In
Buy XTNT
$0.460
-0.0049 (-1.05%)
At Close: Jun 03, 2026
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
08:05am, Wednesday, 16'th Apr 2025
Healthcare Focused Long-term Investors Support Strategic Vision Accelerating Shift to Higher-Margin Orthobiologics Supported by New Product Launches BELGRADE, Mont. , April 16, 2025 /PRNewswire/ -- Xt
Xtant Medical Holdings, Inc. (XTNT) Q4 2024 Earnings Call Transcript
07:12pm, Thursday, 06'th Mar 2025
Xtant Medical Holdings, Inc. (NYSE:XTNT ) Q4 2024 Results Conference Call March 6, 2025 4:30 PM ET Company Participants Brett Maas - Hayden IR Sean Browne - President & Chief Executive Officer Scott N
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results
04:05pm, Thursday, 06'th Mar 2025
Full Year 2024 Revenue Growth of 28% Expects 2025 Revenue of $126 Million to $130 Million Without Need for Additional Capital BELGRADE, MT / ACCESS Newswire / March 6, 2025 / Xtant Medical Holdings, I
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025
08:00am, Friday, 28'th Feb 2025
BELGRADE, MT / ACCESS Newswire / February 28, 2025 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di
Xtant Medical Holdings, Inc. (XTNT) Q3 2024 Earnings Conference Call Transcript
07:07pm, Tuesday, 12'th Nov 2024
Xtant Medical Holdings, Inc. (NYSE:XTNT ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Brett Maas - IR Sean Browne - President and CEO Scott Neils - CFO Conferenc
Xtant Medical Reports Third Quarter 2024 Financial Results
04:05pm, Tuesday, 12'th Nov 2024
Third Quarter Revenue Growth of 12% Reaffirms Full Year 2024 Revenue Guidance of $116 Million to $120 Million Representing Growth of 27% to 31% BELGRADE, MT / ACCESSWIRE / November 12, 2024 / Xtant Me
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference
08:00am, Monday, 11'th Nov 2024
BELGRADE, MT / ACCESSWIRE / November 11, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorde
Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024
10:45am, Thursday, 07'th Nov 2024
BELGRADE, MT / ACCESSWIRE / November 7, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorder
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System
07:00am, Monday, 23'rd Sep 2024
New System Enhances Surgical Efficiency and Provides Versatile Solutions for Complex Spine Procedures BELGRADE, MT / ACCESSWIRE / September 23, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT)
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus
06:00am, Wednesday, 18'th Sep 2024
New Cellular Bone Matrix Designed with Cohesive and Moldable Handling Characteristics BELGRADE, MT / ACCESSWIRE / September 18, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medic
Xtant Medical Holdings, Inc. (XTNT) Q2 2024 Earnings Call Transcript
08:35am, Saturday, 10'th Aug 2024
Xtant Medical Holdings, Inc. (NYSE:XTNT ) Q2 2024 Earnings Conference Call August 9, 2024 9:00 AM ET Company Participants Brett Maas - IR Sean Browne - President and CEO Scott Neils - CFO Conference C
Xtant Medical Announces Closing of $5.0 Million Private Placement
04:05pm, Friday, 09'th Aug 2024
BELGRADE, MT / ACCESSWIRE / August 9, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,
Xtant Medical Announces $5.0 Million Private Placement
07:20am, Thursday, 08'th Aug 2024
BELGRADE, MT / ACCESSWIRE / August 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,
Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference call on August 9, 2024
07:10am, Thursday, 08'th Aug 2024
BELGRADE, MT / ACCESSWIRE / August 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,
Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%
07:05am, Thursday, 08'th Aug 2024
BELGRADE, MT / ACCESSWIRE / August 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders
